-
The clinical applicability of polygenic risk scores for LDL-cholesterol: considerations, current evidence and future perspectives
Cupido, A. J., Tromp, T. R. & Hovingh, G. K., 1 Apr 2021, In: Current opinion in lipidology. 32, 2, p. 112-116 5 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
PCSK9 as predictor for recurrent cardiovascular disease in familial hypercholesterolemia
Reeskamp, L. F., R Tromp, T. & Hovingh, G. K., 1 Mar 2021, In: European journal of preventive cardiology. 28, 3, p. 270-271 2 p.Research output: Contribution to journal › Editorial* › Academic › peer-review
-
Statin therapy reduces plasma angiopoietin-like 3 (ANGPTL3) concentrations in hypercholesterolemic patients via reduced liver X receptor (LXR) activation
Reeskamp, L. F., Tromp, T. R., Huijgen, R., Stroes, E. S. G., Hovingh, G. K. & Grefhorst, A., 1 Dec 2020, In: Atherosclerosis. 315, p. 68-75 8 p.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
